Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

Abstract This study investigated the “real-world” use of ranibizumab for neovascular age-related macular degeneration (nAMD) in Taiwan and assessed the visual outcome. We reviewed the medical records at National Cheng Kung University Hospital, Taiwan, during 2012–2014 for 264 consecutive eyes of 229...

Full description

Bibliographic Details
Main Authors: Yi-Sheng Chang, Wan-Ju Lee, Chen-Chee Lim, Shih-Hao Wang, Sheng-Min Hsu, Yi-Chian Chen, Chia-Yi Cheng, Yu-Ti Teng, Yi-Hsun Huang, Chun-Chieh Lai, Sung-Huei Tseng
Format: Article
Language:English
Published: Nature Portfolio 2018-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-25864-0

Internet

https://doi.org/10.1038/s41598-018-25864-0

Similar Items